https://www.thehindubusinessline.com/news/national/indias-drug-regulatory-authority-steps-up-surveillance-on-generic-glp-1-drugs/article70778406.ece Copy With generic ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

MUMBAI: Natco Pharma has heralded what could become an intense pricing war in India’s pharmaceutical sector by offering its generic version of semaglutide at 90% cheaper than the original weight-loss ...

A Canadian pharmaceutical company, headed by two former executives with the company behind Ozempic, hopes to make a generic version of the weight-loss drug in Edmonton. Data protections on the GLP-1 ...

Did our AI summary help? At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices ...

Takeda is launching a restructuring, targeting nearly $1.3 billion in annual savings. Generic versions of Novo Nordisk's semaglutide reached India in chaotic fashion. Gilead Sciences is paying up to ...

At least a dozen large drugmakers are set to roll out copies of Novo Nordisk’s blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires on Friday. Natco Pharma plans to ...

CLEVELAND — The world of weight-loss medicine is shifting fast — and if you've been priced out of GLP-1 medications, or are watching the space for what's coming next, this week brought several ...

Defense Secretary Pete Hegseth has blocked the promotions of four Army officers — two Black men and two women — to the rank of brigadier general, the New York Times reported Friday. Hegseth’s actions ...

Sarah Mullally was installed on Wednesday at Canterbury Cathedral. Her appointment to the role has been both celebrated and denounced by some factions within the global Anglican Church. By Megan ...